Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Dose Ranging Study of Dysport® (AbobotulinumtoxinA) in the Treatment of Oromandibular Dystonia

NCT01921270 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT01921270
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01921270 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Dose Ranging Study of Dysport® (AbobotulinumtoxinA) in the Treatment of Oromandibular Dystonia
Lead sponsor
Emory University
Phase
Phase 1/2
Overall status
Completed
Start date
August 31, 2013
Completion date
February 8, 2017
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

oral dystonia, tardive dystonia